UP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
Perrigo Company is recalling UP AND UP Childrens Acetaminophen oral suspension due to contamination from a recalled excipient used in manufacturing. The product was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a CGMP deviation (contaminated excipient). The source text does not report any illnesses, injuries, or hospitalizations. The recall is precautionary based on the manufacturing deviation, making it a moderate-severity voluntary precautionary recall.
Plain-English summary
Perrigo Company PLC is recalling UP AND UP Childrens Acetaminophen (Acetaminophen Child Bubble Gum Flavored Oral Suspension, 160 mg/5 ml, 4 FL OZ per bottle) distributed under the NDC 11673-105-26. The recall affects batch 1CK0998 with expiration date 01/31/2023, totaling 4,992 bottles.
The recall was initiated because the product was manufactured using a contaminated excipient that had been recalled by the excipient supplier. This represents a deviation from good manufacturing practices (CGMP).
The affected product was distributed nationwide in the USA. Consumers who have purchased this product should discontinue use and consult their healthcare provider if they have any concerns.
The recalled product
- Product
- UP AND UP CHILDRENS ACETAMINOPHEN (ACETAMINOPHEN)
- Brand
- UP AND UP CHILDRENS ACETAMINOPHEN
- Manufacturer
- Perrigo Company PLC
- Hazard
- contaminated-excipient
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1CK0998
- Exp 01/31/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · UP AND UP CHILDRENS ACETAMINOPHEN
- ModerateUP AND UP Children's Acetaminophen Oral Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27